Headlines

AstraZeneca automates DNA synthesis to slash costs and timelines

AstraZeneca has cut the cost and time needed to complete DNA synthesis by integrating an assembly framework into Benchling.

SCOPE 2023 - will decentralized trials be the hottest topic?

One of the biggest questions being posed at this year's SCOPE summit, is whether the term 'decentralized clinical trials' will become redundant, as it forms the norm.

Aptar announces ‘highly recyclable’ nasal spray

The company outlines that has designed a nasal spray pump that uses no metal parts to deliver OTC formulations.

Say hello to our new look!

Here at OutsourcingPharma, we put our audience at the heart of what we do. For many years, we have provided our readers with a 360-degree view of the pharma landscape and our editorial standards remain unsurpassed.

'Move faster to get patient engagement right' - uMotif's CEO urges the pharma and biotech industries

Steve Rosenberg has been a life science and healthcare executive for 40+ years and is currently CEO of uMotif. He commercialized the first integrated clinical technology suite at Phase Forward/Oracle. Top pharma and biotech executives depend on him for...